Supriya Lifescience Announcements
Transcript of the Earnings Call for the Unaudited Financial Results for quarter and nine months ended December 31, 2025, is enclosed herewith.Kindly take the same...
17 Feb, 2026 | 10:51am • Source: BSE
Audio Recording of the Earnings Call for Unaudited Financial Results of quarter and nine months ended December 31, 2025 is enclosed herewith.
10 Feb, 2026 | 04:25pm • Source: BSE
Supriya Lifescience Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Press Release- Unaudited Financial Results for the Quarter and...
10 Feb, 2026 | 01:24pm • Source: NSE
Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended December 31, 2025 is enclosed.
10 Feb, 2026 | 01:11pm • Source: BSE
Press Release for Unaudited Financial Results for quarter and nine months ended December 31, 2025 is enclosed.
10 Feb, 2026 | 01:06pm • Source: BSE
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the...
09 Feb, 2026 | 07:18pm • Source: BSE
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held...
04 Feb, 2026 | 12:46pm • Source: BSE
Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and...
02 Feb, 2026 | 05:37pm • Source: BSE
Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for quarter ended December 31, 20205 is enclosed.
06 Jan, 2026 | 04:12pm • Source: BSE
Intimation on Credit Rating to the Company is enclosed.
30 Dec, 2025 | 03:40pm • Source: BSE
Intimation for Closure of Trading Window for declaration of the Unaudited Financial Results for quarter and nine months ending on December 31, 2025.Kindly take the...
28 Dec, 2025 | 11:36pm • Source: BSE
Transcript of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2025, is enclosed herewith.Kindly take the...
18 Nov, 2025 | 10:48am • Source: BSE
Investor Presentation is enclosed herewith.
12 Nov, 2025 | 06:02pm • Source: BSE
Unaudited Financial Results for the Quarter and Half year ended September 30,2025 are enclosed herewith.Kindly take the same on record.
12 Nov, 2025 | 05:25pm • Source: BSE
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the...
12 Nov, 2025 | 05:10pm • Source: BSE
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held...
09 Nov, 2025 | 11:17pm • Source: BSE
Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...
05 Nov, 2025 | 08:31pm • Source: BSE
Please find enclosed herewith duly signed certificate dated October 7, 2025 issued by MUFG Intime India Pvt. Ltd. our RTA, confirming compliance under Regulation 74(5)...
13 Oct, 2025 | 11:53am • Source: BSE
Completion of WHO GMP audit at Ambernath facility of the Company and receipt of WHO GMP Certificate for Inhalation Dosages.
01 Oct, 2025 | 12:47pm • Source: BSE
The intimation of closure of Trading Window for trading in securities of the Company by Designated Persons and their immediate relatives for the quarter and...
26 Sep, 2025 | 04:46pm • Source: BSE